Anti-Mouse CD36 Alexa Fluor® 647 (To Be Discontinued. Refer to Alternative Format: APC, cat. 17-0361)

Also known as: GR4, GP3b, GP IIIb, Thrombospondin Receptor

Clone: No.72-1

RUO: For Research Use Only. Not for use in diagnostic procedures.

Attention: To Be Discontinued. Refer to Replacement Format APC, cat. 17-0361

SKU# 51-0361

Cat. No. Size
51-0361-80 25 ug
51-0361-82 100 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Mouse CD36 Alexa Fluor® 647 (To Be Discontinued. Refer to Alternative Format: APC, cat. 17-0361).

Staining of FcR-blocked BALB/c bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC (cat....View More

  • Data for Anti-Mouse CD36 Alexa Fluor® 647 (To Be Discontinued. Refer to Alternative Format: APC, cat. 17-0361).
Description

Description: The No. 72-1 monoclonal antibody reacts with mouse CD36, which is a 88 kDa member of the class B scavenger receptor family. Murine CD36 was discovered using an expression cloning strategy to identify macrophage receptors that recognized oxidized low-density lipoprotein (oxLDL), but not acetylated low-density lipoprotein (LDL). CD36 is a platelet-membrane glycoprotein, but is also expressed on monocytes/macrophages, granulocytes, B lymphocytes, microvascular endothelial cells, adipocytes, skeletal muscle and dendritic cells. The role of CD36 as a scavenger receptor was confirmed by the CD36-deficient mouse, which was defective in the binding and uptake of oxLDL by peritoneal macrophages. In addition to binding oxLDL, CD36 binds other ligands including TSP-1, anionic phospholipids, apoptotic cells, collagen, Plasmodium falciparum-infected erythrocytes and long-chain fatty acids.

Testing also shows staining on some B cells in the bone marrow in addition to the myeloid cells. For more information, please contact tech@ebioscience.com .

Details
Host Rat
Isotype IgG2a, kappa
Reactivity Mouse
Conjugate Alexa Fluor 647
Laser Red Laser
Emit 668 nm
Excite 633 nm
Legal Alexa Fluor® and Pacific Blue® are registered trademarks of and licensed under patents assigned to Molecular Probes, Inc. for research use only. This product is subject to an agreement between Molecular Probes, Inc. and eBioscience, and the manufacture, use, sale or import of this product may be subject to one or more U.S. patents, pending applications and corresponding foreign equivalents, owned by Molecular Probes, Inc. (a wholly owned subsidiary of Invitrogen Corp). The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product for life science research or as an ASR. The buyer cannot use this product for manufacturing or for any other screening (specifically including use in combination with microarrays or High Content Screening) or testing purpose, other than as an ASR. For information on purchasing a license to this product for purposes other than life science research or use as an ASR, contact Molecular Probes, Inc.
Reported Applications Flow Cytometric Analysis
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
12-0361 Anti-Mouse CD36 PE 488 - 561 nm 575 nm FC RUO
17-0361 Anti-Mouse CD36 APC 633 - 647 nm 660 nm FC RUO
14-0361 Anti-Mouse CD36 Purified FC RUO
References

References: Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein.J Biol Chem. 1993 Jun 5;268(16):11811-6.

Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.J Clin Invest. 2000 Apr;105(8):1049-56.

Zhang P, Li W, Wang Y, Hou L, Xing Y, Qin H, Wang J, Liang Y, Han H. Identification of CD36 as a new surface marker of marginal zone B cells by transcriptomic analysis.Mol Immunol. 2007 Jan;44(4):332-7.